Metabolomics

LECO’s high-resolution mass spectrometry and GC×GC platforms provide comprehensive metabolite profiling, helping researchers discover biomarkers, understand disease, and analyze complex biological samples.

RW-ASMS13-LPSS-123
415-956-003
Jan Hazebroek, PhD., from Corteva Agriscience, discusses the impacts and benefits that the Pegasus BT had in their laboratory's high-throughput metabolomics research.
401-952-739
Three GC/MS Experts embrace the 'spookier' side of mass spectrometry. Jane Hill, from the University of British Columbia, brings her expertise on 'omics and medical diagnostics in Disease: Trick or Treat? Metabolomics is changing how we monitor ou...
John Heim & Jeff Patrick [LECO] discuss GCxGC-TOFMS benefits to metabolomic study, with various experiment results analyzed.
JB-ASMS11-LPSS-036
Cannabimimetic compounds (compounds that mimic cannabinoids) were analyzed by High-Resolution GC-TOFMS.
401-956-004
Metabolomics is particularly challenging for the separation science community, demanding application of high-end iterations of various techniques. LECO, in collaboration with The Analytical Scientist, explore non-targeted analyses in this complex ...
DA-IMSC16-LPSS-206
401-956-006
Oliver Fiehn, PhD. (UC Davis) discusses utilizing open access metabolomics databases for data analysis and comparison. Several database resources are presented.
JB-ASMS14-LPSS-150
This application compendium explores the integration of hydrogen as a carrier gas in high-resolution gas chromatography-time-of-flight mass spectrometry (GC-TOFMS) systems, specifically the Pegasus® GC-HRT. Addressing the challenges posed by the d...
PS-PCON09-LPSS-015
Breath analysis is a non-invasive technique for multiple disease biomarkers. High humidity in breath samples provide unique challenges for analysis.